Lonza Pharma & Biotech

@LonzaPB

We provide contract development and manufacturing services that enable pharma and biotech companies to bring medicines to patients in need.

Vrijeme pridruživanja: studeni 2017.

Tweetovi

Blokirali ste korisnika/cu @LonzaPB

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @LonzaPB

  1. 4. velj

    How is helping address manufacturing and containment challenges? Join us at the Highly Potent APIs Summit 2020 on 19-21 February in Prague, CZ, to learn more

    Poništi
  2. 29. sij

    Getting your candidates from discovery to development can be complex and risky – come meet our tech experts in the US on Feb 10–14 (East Coast) & Feb 17–21 (West Coast) to talk about how we can help de-risk your candidate. Contact us today: appliedproteinservices@lonza.com

    Poništi
  3. 29. sij

    Our latest Peer-reviewed article on the long-term stability of iPSCs authored by our Process Development team in Houston is now available on PubMed.

    Poništi
  4. 29. sij

    announced a clinical manufacturing agreement with for their RP-L201 treatment of Leukocyte Adhesion Deficiency-I (LAD-I). This will leverage Lonza’s lentiviral vector technologies at our Houston, TX and Geleen, Netherlands cGMP sites

    Poništi
  5. 28. sij

    How is addressing the growing demand for drug products? In an interview with , Maurits Janssen discussed Lonza’s focus on manufacturing flexibility and capacity to bring these molecules from concept to commercialization :

    Poništi
  6. proslijedio/la je Tweet
    28. sij

    BioSeedEvent was a huge success - take a look at the highlights from the event! If you missed it this year be sure not to in 2021 but don't forget there is another opportunity to showcase your company through our platform BioLaunchpad at on 28/29 April in London

    Poništi
  7. 27. sij

    Congratulations to Luk H. Vandenberghe and the team at Massachusetts Eye and Ear on this great discovery! We are proud and feel privileged to have supported such exciting research

    Poništi
  8. 24. sij

    The opportunities for commercial & market expansion in China are fueling tremendous growth. At the 3rd Annual in San Francisco (CA), Rhona McIntyre, Head of Commercial Development Biologics Guangzhou, joined an insightful panel discussion.

    Poništi
  9. 24. sij

    Dr. Behnam Baghbaderani introduces the approach to process development and addressing the challenges with therapies in :

    Poništi
  10. 23. sij

    Read the interview with Lonza's Nicole Wellens, Global Product Manager for BioTherapeutics Media, and learn how our newly launched eCHO™ Feed media protect the integrity of proteins by minimizing lactate generation.

    Poništi
  11. 22. sij

    ’s Charles Christy discusses what lies ahead for in 2020, including single-use systems for mammalian manufacturing and hybrid processes for faster biologics manufacturing in :

    Poništi
  12. 21. sij

    An exciting day of presentations yesterday at . Looking forward to next years event!

    Poništi
  13. proslijedio/la je Tweet
    20. sij

    Our first showcase session of kindly sponsored by , is just starting. We will see pitches from , Vidergen, Kinomica, , Bioarchitech, Emenda Therapeutics,Reflection Therapeutics, and Serengen

    Poništi
  14. proslijedio/la je Tweet
    20. sij
    Poništi
  15. 17. sij

    Join at in London on Monday January 20th. Meet us and hear from some of the companies in participating. We look forward to seeing you there!

    Poništi
  16. proslijedio/la je Tweet
    14. sij
    Poništi
  17. 15. sij

    Time to market for half that of other Tx (~3.5yrs) so vital to get dev right first time: Alberto Santagostino.

    Poništi
  18. 14. sij

    Lipid formulations are a simple and effective pathway to the clinic. Join our experts for this on-demand discussion.

    Poništi
  19. 13. sij

    looks forward to participating in in London on January 20th. Join us for session one to hear from some of the companies participating.

    Poništi
  20. 10. sij

    We were proud associate sponsors of the Cell Therapy Manufacturing and Gene Therapy Congress in Amsterdam. Behnam Ahmadian joined as a keynote speaker. Click here to listen to his presentation:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·